Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KDM4B | CTRPv2 | pan-cancer | AAC | -0.099 | 0.02 |
mRNA | ADORA2A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | ACTL6B | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | ABCB4 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | SNTA1 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | TIMM23B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | TAF7 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
mRNA | IPO13 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | MAP3K1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
mRNA | CHRAC1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |